Literature DB >> 8119365

Prospective study of verocytotoxin-producing, enteroaggregative and diffusely adherent Escherichia coli in different diarrhoeal states.

M G Brook1, H R Smith, B A Bannister, M McConnell, H Chart, S M Scotland, A Sawyer, M Smith, B Rowe.   

Abstract

One hundred and eighty-one stool specimens from patients with various types of diarrhoea (135 patients) or from non-diarrhoeal controls (23 acute medical patients, 23 inflammatory bowel disease in remission) were investigated using a colony-blot DNA hybridization assay for the presence of Verocytotoxin-producing (VTEC), enteroaggregative (EAggEC) and diffusely adherent (DAEC) Escherichia coli. Twelve patients had probe-positive EAggEC in the stool and 8 of these had diarrhoea, 6 following recent travel. Eight patients had DAEC, 7 of whom had travellers' diarrhoea. Six of 10 (60%) travellers with gastroenteritis, but without a recognized enteric pathogen, were positive for EAggEC (4) or DAEC (2). Five of 10 (50%) travellers with gastroenteritis related to a recognized enteric pathogen also had DAEC identified in their stool. Of the 23 acute medical control patients 11 had been abroad, 4 of these were immigrants and had EAggEC. VTEC were not found and, with one exception, immunoassays for antibodies to E. coli O 157 and O 2 lipopolysaccharides were negative.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119365      PMCID: PMC2271496          DOI: 10.1017/s0950268800057423

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  17 in total

1.  Adhesion to cells in culture and plasmid profiles of enteropathogenic Escherichia coli isolated from outbreaks and sporadic cases of infant diarrhoea.

Authors:  S M Scotland; G A Willshaw; H R Smith; R J Gross; B Rowe
Journal:  J Infect       Date:  1989-11       Impact factor: 6.072

2.  A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen.

Authors:  B Baudry; S J Savarino; P Vial; J B Kaper; M M Levine
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

3.  Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis.

Authors:  H von Wulffen; H Rüssmann; H Karch; T Meyer; M Bitzan; T C Kohrt; S Aleksic
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

4.  Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory.

Authors:  C W Walker; R Upson; R E Warren
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

5.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

6.  Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157.

Authors:  G A Willshaw; S M Scotland; H R Smith; B Rowe
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

7.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli.

Authors:  J J Mathewson; P C Johnson; H L DuPont; D R Morgan; S A Thornton; L V Wood; C D Ericsson
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

10.  Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India.

Authors:  M K Bhan; P Raj; M M Levine; J B Kaper; N Bhandari; R Srivastava; R Kumar; S Sazawal
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

View more
  3 in total

1.  Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls.

Authors:  C Schultsz; M Moussa; R van Ketel; G N Tytgat; J Dankert
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

Review 2.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins.

Authors:  Fréderic Bétis; Patrick Brest; Véronique Hofman; Julie Guignot; Imad Kansau; Bernard Rossi; Alain Servin; Paul Hofman
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.